Decibel Cannabis signs UK licensing deal with Hilltop Leaf
Canadian operator Decibel Cannabis has entered a licensing arrangement with Hilltop Leaf in the UK market, according to StratCann.
FILE — dealmaking · Perzon SEO / CC BY 2.0Decibel Cannabis has signed a licensing deal with Hilltop Leaf in the United Kingdom, marking another entry point for the Canadian operator into the UK medical cannabis market. The move comes as several established cannabis operators—including Tilray, Canopy Growth, Curaleaf Laboratories, and others—have expanded or announced UK production and distribution capacity over recent months.
The licensing structure suggests Decibel is pursuing a partnership model rather than full facility acquisition, a pattern consistent with other recent UK market entries by North American operators. The UK medical cannabis sector continues to consolidate around production and distribution infrastructure, with the Food Standards Agency having recommended approval of CBD products as novel foods in September.
Watch for whether Decibel announces specific therapeutic focus areas or patient volumes tied to the Hilltop Leaf arrangement, and whether the licensing deal leads to facility capacity announcements—critical metrics as the UK market approaches projected demand of 140,000+ medical cannabis patients by year-end.
Original report: StratCann ↗